ArticleInterdisciplinary sciences, computational life sciences2022
Enabling Artificial Intelligence for Genome Sequence Analysis of COVID-19 and Alike Viruses.
Article in Interdisciplinary sciences, computational life sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of artificial intelligence-based COVID-19 modeling on multimodal genetic information.Progress in biophysics and molecular biology · 2023Pooled it
- A semantic FAIRness framework for epidemiological analysis of COVID-19 data in the UAE.Frontiers in public health · 2026Review
- Volatile organic compounds (VOCs) detection for the identification of bacterial infections in clinical wound samples.Talanta · 2025Review
- PRCFX-DT: a new graph-based approach for feature selection and classification of genomic sequences.BMC bioinformatics · 2025Article
- Article
- Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.PloS one · 2024Article
- Real-time infectious disease endurance indicator system for scientific decisions using machine learning and rapid data processing.PeerJ. Computer science · 2024Article
- The Progression in Developing Genomic Resources for Crop Improvement.Life (Basel, Switzerland) · 2023Review
- Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.Computers in biology and medicine · 2023Article
- The use of artificial intelligence for delivery of essential health services across WHO regions: a scoping review.Frontiers in public health · 2023Article
- DRPADC: A novel drug repositioning algorithm predicting adaptive drugs for COVID-19.Computers & chemical engineering · 2022Article
- A sustainable advanced artificial intelligence-based framework for analysis of COVID-19 spread.Environment, development and sustainability · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Recent pandemic of COVID-19 (Coronavirus) caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has been growing lethally with unusual speed. It has infected millions of people and continues a mortifying influence on the global population's health and well-being. In this situation, genome sequence analysis and advanced artificial intelligence techniques may help researchers and medical experts to understand the genetic variants of COVID-19 or SARS-CoV-2. Genome sequence analysis of COVID-19 is crucial to understand the virus's origin, behavior, and structure, which might help produce/develop vaccines, antiviral drugs, and efficient preventive strategies. This paper introduces an artificial intelligence based system to perform genome sequence analysis of COVID-19 and alike viruses, e.g., SARS, middle east respiratory syndrome, and Ebola. The system helps to get important information from the genome sequences of different viruses. We perform comparative data analysis by extracting basic information of COVID-19 and other genome sequences, including information of nucleotides composition and their frequency, tri-nucleotide compositions, count of amino acids, alignment between genome sequences, and their DNA similarity information. We use different visualization methods to analyze these viruses' genome sequences and, finally, apply machine learning based classifier support vector machine to classify different genome sequences. The data set of different virus genome sequences are obtained from an online publicly accessible data center repository. The system achieves good classification results with an accuracy of 97% for COVID-19, 96%, SARS, and 95% for MERS and Ebola genome sequences, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.